Financial Performance - Revenue for the year ended December 31, 2025, was HKD 99,799,000, a decrease of 23.1% from HKD 129,680,000 in 2024[3] - Gross profit for 2025 was HKD 80,264,000, resulting in a gross margin of 80.4%, compared to a gross margin of 69.5% in 2024[3] - Profit before tax for 2025 was HKD 13,987,000, a significant recovery from a loss of HKD 68,031,000 in 2024[3] - The company reported a profit attributable to owners of HKD 13,350,000 for 2025, compared to a loss of HKD 68,338,000 in the previous year[4] - Basic and diluted earnings per share for 2025 were HKD 0.05, a turnaround from a loss per share of HKD 0.28 in 2024[5] - Total comprehensive income for the year was HKD 10,009,000, compared to a total comprehensive loss of HKD 66,170,000 in 2024[5] - The segment performance for footwear products showed a loss of HKD 29,551,000 in 2025, compared to a loss of HKD 39,926,000 in 2024, indicating an improvement in performance[26][27] - The company recorded a pre-tax profit of approximately HKD 14 million for the year, compared to a pre-tax loss of approximately HKD 68 million in 2024, mainly due to gains from asset sales[66] Revenue Breakdown - For the fiscal year ending December 31, 2025, the company reported revenue from footwear sales of HKD 83,562,000, a decrease of 32.9% from HKD 124,455,000 in the previous year[22] - Retail support service revenue increased significantly to HKD 16,237,000 from HKD 5,225,000, marking a growth of 210.5%[22] - The total revenue from Hong Kong for the year ended December 31, 2025, was HKD 89,639,000, a decrease from HKD 112,883,000 in 2024, indicating a decline of approximately 20%[30] - In 2025, the company's footwear business revenue was approximately HKD 99.8 million, a decrease of 23.1% compared to HKD 129.7 million in 2024, primarily due to weak consumer sentiment amid ongoing economic uncertainty[57] Assets and Liabilities - The company's total assets decreased to HKD 71,152,000 in 2025 from HKD 112,154,000 in 2024, primarily due to a reduction in current assets[6] - Non-current liabilities decreased to HKD 3,495,000 in 2025 from HKD 8,465,000 in 2024, reflecting a reduction in employee benefit obligations and lease liabilities[7] - The company has a current liability exceeding current assets by approximately HKD 70,915,000 and total liabilities exceeding total assets by about HKD 54,440,000 as of December 31, 2025[19] - The asset-liability ratio improved to approximately -47.5% as of December 31, 2025, compared to -63.9% in 2024, attributed to the profit recorded during the year[69] Operational Challenges - The company is facing significant uncertainty regarding its ability to continue as a going concern, which may require adjustments to asset valuations and liabilities if it cannot sustain operations[21] - The company has not received any repayments on overdue loans as of the report date, constituting a default event[39] - The company is implementing cost control measures to improve operational cash flow, including close monitoring of sales, distribution costs, and administrative expenses[20] Corporate Governance and Compliance - The company has not applied new accounting standards that are not yet effective, indicating a stable approach to financial reporting[11] - The independent auditor's report did not express an opinion on the group's consolidated financial statements due to significant issues[84] - The group has complied with the corporate governance code, except for the vacancy of the chairman position[79] Asset Sales and Liquidation - The company is in the process of liquidating Shang Ying Medical, which is currently under bankruptcy review, affecting its financial reporting and control over assets[18] - The sale of Shang Ying International Group was completed for a cash consideration of HKD 1, resulting in a net loss of HKD 34,668,000[44] - The sale of Shang Ying Retail Group was completed for a cash consideration of HKD 1, resulting in a net gain of HKD 3,894,000[46] - The sale of Shang Ying Capital Group was completed for a cash consideration of HKD 500,000[48] Employee and Operational Metrics - The company incurred a total of HKD 47,329,000 in employee costs for the year ended December 31, 2025, down from HKD 56,151,000 in 2024[31] - The group employed 108 staff members as of December 31, 2025, a decrease from 111 in the previous year[76] - The company has 31 retail points in Hong Kong and 4 in Macau as of December 31, 2025, an increase from 27 and 3 respectively in 2024[59] Future Outlook and Meetings - The company plans to focus on diversifying its footwear product offerings and exploring potential business collaborations to introduce new brands with growth potential and high margins[58] - The company will hold its annual general meeting on May 20, 2026, to discuss shareholder matters[97] - Share transfer registration will be suspended from May 15, 2026, to May 20, 2026, to determine voting eligibility at the annual general meeting[98]
TATA健康(01255) - 2025 - 年度业绩